Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?

Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?

Vera Himmelsbach, Christine Koch, Jörg Trojan, Fabian Finkelmeier Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, GermanyCorrespondence: Jörg Trojan, Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, F...

Full description

Bibliographic Details
Main Authors: Himmelsbach V, Koch C, Trojan J, Finkelmeier F
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
systemic therapy
checkpoint inhibitors
neoadjuvant treatment
adjuvant treatment
Online Access:https://www.dovepress.com/systemic-drugs-for-hepatocellular-carcinoma-what-do-recent-clinical-tr-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/systemic-drugs-for-hepatocellular-carcinoma-what-do-recent-clinical-tr-peer-reviewed-fulltext-article-JHC

Similar Items